Formulation and evaluation of bio compounds of berberis aristata compressed tablets in psoriasis treatment

Authors

DOI:

https://doi.org/10.26452/ijcpms.v2i4.483

Keywords:

Berberis aristata, psoriasis, microcrystalline cellulose, pre compression

Abstract

The objective of the research is to design and evaluate the bio compounds of Berberis aristata (BCBA) compressed tablets in psoriasis treatment. BCBA of dose 300 mg was compressed into tablets by employing microcrystalline cellulose (MCC) and sodium starch glycolate (SSG) as superdisintegrant and necessary excipients by employing direct compression method. The fourier transform infrared (FTIR) results depicts no incompatibility among the drug and excipients. The study results of pre compression parameters have excellent flow qualities and compressibility. The post-compression parameters show that the results are within the specified standard deviations. SSG exhibit better disintegrating property than MCC. The optimized formulation F6 showed better disintegrating property and In vitro drug release studies in comparison with marketed formulation.

Downloads

Download data is not yet available.

Published

2022-12-23

How to Cite

Bandarapalle, K., Pathakota Bhuvan Kumar Reddy, Ayesha T, Mohit Ragavendra M R, Dondapati Tejaswi, Sindhu P, & Manoj Kumar B. (2022). Formulation and evaluation of bio compounds of berberis aristata compressed tablets in psoriasis treatment. International Journal of Clinical Pharmacokinetics and Medical Sciences, 2(4), 153–158. https://doi.org/10.26452/ijcpms.v2i4.483

Issue

Section

Original Article

Most read articles by the same author(s)